Oncolytic Virus Therapy Market Trends, Size, Forecast - 2018-2023

Oncolytic virus therapy is based on the treatment through a virus that infects and kills cancer cells. These oncolytic viruses not only destroy the cancerous cell, also prevents the growth of tumour cells by stimulating the host anti-tumour immune responses. The first oncolytic virus therapy was approved in 2015, it is still is in the nascent stage of being considered as suitable and effective cancer therapy. The first oncolytic virus was the genetically modified herpes simplex virus type I that is Talimogene laherparepvec (T-VEC) that reported to be clinically beneficial for patients with melanoma.

Request a free sample of our report on Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/oncolytic-virus-therapy-market

Oncolytic virus therapy market is anticipated to grow at a decent growth rate during the forecast period. Most of the oncolytic virus therapy in clinical trials are in preclinical phase followed by Phase-I trials. At present, two three oncolytic drugs have been commercialised, however, approximately 48 oncolytic virus therapies are in clinical trials. The factors that are fuelling the growth of the market includes higher incidence and prevalence rate of cancer. Melanoma is one of the cancers that has been prevalent across the US region. The first oncolytic virus success over chemotherapy and radiotherapy have paved ways for developing them for other cancers. The other factors are the side effects associated with conventional cancer therapies. Chemotherapy and radiation therapy cause certain side-effects such as prolonged exposure to radiation may cause skin cancer.

A full report of Oncolytic Virus Therapy Market Is available at https://www.omrglobal.com/industry-reports/oncolytic-virus-therapy-market

Oncolytic Virus Therapy Market Segmentation

By Product
• HSV-Based Oncolytic Viruses
• Adenoviruses-Based Oncolytic Viruses
• Vaccinia Virus-Based Oncolytic Viruses
• Vesicular Stomatitis Virus-Based Oncolytic Viruses
• Newcastle Disease Virus-Based Oncolytic Viruses

By Application
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others

Competitive Landscape

Regional Analysis
• North American
o United States
o Canada

• Europe
o UK
o Germany
o Italy
o Spain
o France
o ROE

• Asia Pacific
o India
o China
o Japan
o ROAPAC

• Rest of the World

Company Profiles
• Amgen
• BioVex Inc.,
• Cold Genesys, Inc.
• Crusade Laboratories
• Cynvec LLC
• Genelux Corp.
• JennerRex Co. Ltd
• Lokon Pharma AB
• MediGene AG
• Merck

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/oncolytic-virus-therapy-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.